Cargando…
Chlorhexidine oral rinses for symptomatic COPD: a randomised, blind, placebo-controlled preliminary study
OBJECTIVES: Determine the effect of twice-daily chlorhexidine oral rinses on oral and lung microbiota biomass and respiratory symptoms. SETTING: Single centre. PARTICIPANTS: Participants were aged 40–85 with chronic obstructive pulmonary disease (COPD) and chronic productive cough or COPD exacerbati...
Autores principales: | Pragman, Alexa A, Fieberg, Ann M, Reilly, Cavan S, Wendt, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672026/ https://www.ncbi.nlm.nih.gov/pubmed/34903538 http://dx.doi.org/10.1136/bmjopen-2021-050271 |
Ejemplares similares
-
634. Chlorhexidine Oral Rinses to Alter the Oral and Sputum Microbiota in COPD (CLIMB): a Randomized, Double-blinded, Placebo-controlled, Parallel-group Pilot Study
por: Pragman, Alexa, et al.
Publicado: (2020) -
Antimicrobial efficacy of Xylitol, Probiotic and Chlorhexidine mouth rinses among children and elderly population at high risk for dental caries – A Randomized Controlled Trial
por: KRUPA, NC, et al.
Publicado: (2022) -
Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19
por: Bosaeed, Mohammad, et al.
Publicado: (2021) -
The effect of simvastatin on inflammatory cytokines in community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial
por: Viasus, Diego, et al.
Publicado: (2015) -
Early use of Antibiotics for at Risk CHildren with InfluEnza (ARCHIE): protocol for a double-blind, randomised, placebo-controlled trial
por: Wang, Kay, et al.
Publicado: (2018)